Clinical Trial Detail

NCT ID NCT02847429
Title Randomized Trial of Crenolanib in Subjects With D842V Mutated GIST
Recruitment Recruiting
Gender both
Phase Phase III
Variant Requirements Yes
Sponsors Arog Pharmaceuticals, Inc.
Indications

gastrointestinal stromal tumor

Therapies

Crenolanib

Age Groups: adult senior

Additional content available in CKB BOOST